Full View

Effect of empagliflozin on hemodynamics in patients with heart failure and reduced ejection fraction

M Omar, J Jensen, PH Frederiksen, C Kistorp… - Journal of the American …, 2020 - jacc.org
Background Inhibition of the sodium-glucose cotransporter-2 (SGLT2i) improves outcomes
in patients with heart failure (HF) and reduced ejection fraction (HFrEF), but the mechanism …
被引用次数：78 相关文章

Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction

M Omar, J Jensen, PH Frederiksen… - Journal of the …, 2020 - mayoclinic.elsevierpure.com
Background: Inhibition of the sodium-glucose cotransporter-2 (SGLT2i) improves outcomes
in patients with heart failure (HF) and reduced ejection fraction (HFrEF), but the mechanism …

Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction

M Omar, J Jensen, PH Frederiksen… - Journal of the …, 2020 - research.regionh.dk
BACKGROUND: Inhibition of the sodium-glucose cotransporter-2 (SGLT2i) improves
outcomes in patients with heart failure (HF) and reduced ejection fraction (HFrEF), but the …

Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction

M Omar, J Jensen, PH Frederiksen… - Journal of the …, 2020 - portal.findresearcher.sdu.dk
Background: Inhibition of the sodium-glucose cotransporter-2 (SGLT2i) improves outcomes
in patients with heart failure (HF) and reduced ejection fraction (HFrEF), but the mechanism …

Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction

M Omar, J Jensen, PH Frederiksen, CMN Kistorp… - ikm.ku.dk
Background: Inhibition of the sodium-glucose cotransporter-2 (SGLT2i) improves outcomes
in patients with heart failure (HF) and reduced ejection fraction (HFrEF), but the mechanism …

Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction.

M Omar, J Jensen, PH Frederiksen… - Journal of the …, 2020 - europepmc.org
Background Inhibition of the sodium-glucose cotransporter-2 (SGLT2i) improves outcomes
in patients with heart failure (HF) and reduced ejection fraction (HFrEF), but the mechanism …

Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction

M Omar, J Jensen, PH Frederiksen, C Kistorp… - 2020 - pubmed.ncbi.nlm.nih.gov
Background Inhibition of the sodium-glucose cotransporter-2 (SGLT2i) improves outcomes
in patients with heart failure (HF) and reduced ejection fraction (HFrEF), but the mechanism …
[HTML] sciencedirect.com

[HTML][HTML] Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction

M Omar, J Jensen, PH Frederiksen, C Kistorp… - Journal of the American …, 2020 - Elsevier
Background Inhibition of the sodium-glucose cotransporter-2 (SGLT2i) improves outcomes
in patients with heart failure (HF) and reduced ejection fraction (HFrEF), but the mechanism …

Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction

M Omar, J Jensen, PH Frederiksen, CMN Kistorp… - core.ku.dk
Background: Inhibition of the sodium-glucose cotransporter-2 (SGLT2i) improves outcomes
in patients with heart failure (HF) and reduced ejection fraction (HFrEF), but the mechanism …

[引用][C] Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction

Journal of the American College of Cardiology, 2020 - core.ku.dk
Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced
Ejection Fraction - Fitmum: Fitness for good health of mother and child Topic navigation …